{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1553, 
        1560
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1819, 
        1826
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1561, 
        1570
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1827, 
        1836
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        920, 
        943
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2099, 
        2119
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1376, 
        1403
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1417, 
        1427
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1490, 
        1494
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1642, 
        1646
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1770, 
        1774
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        498, 
        527
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1571, 
        1578
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1837, 
        1844
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1495, 
        1501
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1647, 
        1653
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1775, 
        1781
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1510, 
        1515
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1655, 
        1660
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1455, 
        1456
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1487, 
        1489
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1639, 
        1641
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1739, 
        1740
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Marin Medical Laboratories^05D0604317^CLIA|eMARCPlus|CA Cancer Registry|20170918020006||ORU^R01^ORU_R01|201709180200060001|P|2.5.1|CA||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-MS-007604^PathSys^05D0604317^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170907000000|||||||20170907000000|&Slide Consult, Comprehensive |1972585941^^^^^^MD^^CMS^D^^^NPI||||||20170908000000|||F||||||C50.912^Malignant neoplasm of unspecified site of left female breast^I10|1841308558&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe following are received from California Pacific Medical Center\n Pathology Department, San Francisco, California:\n - 10 glass slides labeled \"CPP-17-20227, \" and a pathology\n report (outside #CPP-17-20227) prepared by Dr. Tom Eiman dated 8/3/17.\n - 23 glass slides labeled \"CPP-17-21829, \" and a pathology\n report (outside report #CPP-17-21829) prepared by Dr. Shine Yun dated\n 8/23/17.\n\n\nPath report.relevant Hx\n\nClinical - 71 year old female with left breast LCIS. History - 09/16/2002  02-MS-12644  SF50008\n RETROPERITONEAL LYMPH NODE, FINE NEEDLE ASPIRATION:\n LYMPHOMA, B-CELL TYPE, CONSISTENT WITH FOLLICULAR LYMPHOMA, WITH\n FEATURES SUGGESTIVE OF TRANSFORMATION TO HIGH GRADE LYMPHOMA; SEE\n COMMENT.\n 03/29/2002  02-MS-04398  SF50008\n RETROPERITONEUM, LYMPH NODE, FNA:\n MALIGNANT LYMPHOMA, B-CELL, FOLLICULAR TYPE, GRADE 1. SEE COMMENT.\n\n\nPath report.final diagnosis\n\nMICROSCOPIC DIAGNOSIS:\n Review of outside slides\n 1. Outside case #CPP-17-20227:\n A. Left breast tissue, 12:00, stereotactic guided core biopsy:\n - Lobular carcinoma in situ (LCIS), with associated microcalcifications;\n see comment.\n B. Left breast, 12:00, stereotactic core biopsy:\n Atypical lobular hyperplasia (ALH); see comment.\n 2. Outside case CPP-17-21829:\n Left breast, needle localized lumpectomy:\n Focal lobular carcinoma in situ (LCIS), pleomorphic type, 5.0 mm in\n greatest dimension, adjacent to prior biopsy site changes, in a\n background of atypical lobular hyperplasia (ALH); LCIS approaches to\n within 0.2 mm of the inked superficial medial-inferior margin; see\n comment. /*\n\n\nPath report.comments\n\ncomments - We concur with the submitting pathologists' diagnoses.\n In case CPP-17-20227 the LCIS is negative for E-cadherin, is ER positive\n (strong 100%), PR negative (0%) and Ki67 positive in 10% of cells.\n Synoptic comment for CPP-17-21829:\n Left breast, needle localized lumpectomy:\n - Lobular carcinoma in situ (LCIS).\n - Carcinoma in situ nuclear grade/type: Pleomorphic type.\n - Associated microcalcifications: Present in benign ducts.\n - Associated comedonecrosis: Not identified.\n - Greatest extent on a single core: 5.0 mm.\n - Margins: Negative. LCIS approaches to within 0.2 mm of the superficial\n medial-inferior margin.\n - Prognostic/predictive immunohistochemical studies:\n    ER: positive, 100%, strong staining (done on prior biopsy).\n - Additional findings: Atypical lobular hyperplasia (ALH).\n - Lymph nodes: None submitted.\n - AJCC pathologic stage: pTis(LCIS)NX.\n\n\n"
}